Camlin Fine Sciences has informed that the temporarily closure of Diphenol Plant of its wholly owned subsidiary, CFS Europe SPA situated in Ravenna, Italy shall be extended on account of continuing difficult macro?economic situation in Europe coupled with low pricing and weak demand across the industry. Such closure shall continue until the situation improves for the resumption of the operation of the plant. For the financial year ended March 31, 2023, CFS Europe SPA’s Revenue from Operation was Rs488.23 crore which was 29% of consolidated revenue and its Net Worth for the aforesaid period was Rs. 308.66 crore which was 40% of the consolidated net worth.
The above information is a part of company’s filings submitted to BSE.
